The Effect of Glioblastoma PSMA Expression Following Tumour VEGF Blockade From Bevacizumab

Clinical trial NCT07052877 · RECRUITING

Trial details

NCT number: NCT07052877
Sponsor: Royal North Shore Hospital
Status: RECRUITING
Study type: OBSERVATIONAL

Glioblastoma Glioblastoma Multiforme (GBM)

Start date: 2025-12-11
Primary completion: 2027-07-01
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.